% alzhub.org library filter % Source: https://alzhub.org/research?author=Cummings+J % 35 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{emre2007-17542011, author = {Emre, M. and Aarsland, D. and Brown, R. and Burn, D. J. and Duyckaerts, C. and Mizuno, Y. and Broe, G. A. and Cummings, J. and others}, title = {{Clinical diagnostic criteria for dementia associated with Parkinson's disease}}, journal = {Movement disorders : official journal of the Movement Disorder Society}, year = {2007}, doi = {10.1002/mds.21507}, pmid = {17542011}, url = {https://doi.org/10.1002/mds.21507} } @article{winblad2007-17380489, author = {Winblad, B. and Cummings, J. and Andreasen, N. and Grossberg, G. and Onofrj, M. and Sadowsky, C. and Zechner, S. and Nagel, J. and others}, title = {{A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule}}, journal = {International journal of geriatric psychiatry}, year = {2007}, doi = {10.1002/gps.1788}, pmid = {17380489}, url = {https://doi.org/10.1002/gps.1788} } @article{tariot2011-21810649, author = {Tariot, P. N. and Schneider, L. S. and Cummings, J. and Thomas, R. G. and Raman, R. and Jakimovich, L. J. and Loy, R. and Bartocci, B. and others}, title = {{Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease}}, journal = {Archives of general psychiatry}, year = {2011}, doi = {10.1001/archgenpsychiatry.2011.72}, pmid = {21810649}, url = {https://doi.org/10.1001/archgenpsychiatry.2011.72} } @article{kurlan2007-17452579, author = {Kurlan, R. and Cummings, J. and Raman, R. and Thal, L. and {Alzheimer's Disease Cooperative Study Group}}, title = {{Quetiapine for agitation or psychosis in patients with dementia and parkinsonism}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000260060.60870.89}, pmid = {17452579}, url = {https://doi.org/10.1212/01.wnl.0000260060.60870.89} } @article{coleman2025-39862881, author = {Coleman, K. K. L. and Berry, S. and Cummings, J. and Hsiung, G. R. and Laforce, R. and Huey, E. and Ducharme, S. and Tartaglia, M. C. and Mendez, M. F. and Onyike, C. and others}, title = {{Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial}}, journal = {The Lancet Neurology}, year = {2025}, doi = {10.1016/S1474-4422(24)00456-3}, pmid = {39862881}, url = {https://doi.org/10.1016/S1474-4422(24)00456-3} } @article{scheltens2021-33667416, author = {Scheltens, P. and De Strooper, B. and Kivipelto, M. and Holstege, H. and Chételat, G. and Teunissen, C. E. and Cummings, J. and van der Flier, W. M.}, title = {{Alzheimer's disease}}, journal = {Lancet (London, England)}, year = {2021}, doi = {10.1016/s0140-6736(20)32205-4}, pmid = {33667416}, url = {https://doi.org/10.1016/s0140-6736(20)32205-4} } @article{mckeith2005-16237129, author = {McKeith, I. G. and Dickson, D. W. and Lowe, J. and Emre, M. and O'Brien, J. T. and Feldman, H. and Cummings, J. and Duda, J. E. and others}, title = {{Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium}}, journal = {Neurology}, year = {2005}, doi = {10.1212/01.wnl.0000187889.17253.b1}, pmid = {16237129}, url = {https://doi.org/10.1212/01.wnl.0000187889.17253.b1} } @article{dubois2007-17616482, author = {Dubois, B. and Feldman, H. H. and Jacova, C. and Dekosky, S. T. and Barberger-Gateau, P. and Cummings, J. and Delacourte, A. and Galasko, D. and others}, title = {{Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria}}, journal = {The Lancet. Neurology}, year = {2007}, doi = {10.1016/s1474-4422(07)70178-3}, pmid = {17616482}, url = {https://doi.org/10.1016/s1474-4422(07)70178-3} } @article{weintraub2009-19474567, author = {Weintraub, S. and Salmon, D. and Mercaldo, N. and Ferris, S. and Graff-Radford, N. R. and Chui, H. and Cummings, J. and DeCarli, C. and others}, title = {{The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery}}, journal = {Alzheimer disease and associated disorders}, year = {2009}, doi = {10.1097/wad.0b013e318191c7dd}, pmid = {19474567}, url = {https://doi.org/10.1097/wad.0b013e318191c7dd} } @article{molinuevo2018-30488277, author = {Molinuevo, J. L. and Ayton, S. and Batrla, R. and Bednar, M. M. and Bittner, T. and Cummings, J. and Fagan, A. M. and Hampel, H. and others}, title = {{Current state of Alzheimer's fluid biomarkers}}, journal = {Acta neuropathologica}, year = {2018}, doi = {10.1007/s00401-018-1932-x}, pmid = {30488277}, url = {https://doi.org/10.1007/s00401-018-1932-x} } @article{ferris2006-17135805, author = {Ferris, S. H. and Aisen, P. S. and Cummings, J. and Galasko, D. and Salmon, D. P. and Schneider, L. and Sano, M. and Whitehouse, P. J. and others}, title = {{ADCS Prevention Instrument Project: overview and initial results}}, journal = {Alzheimer disease and associated disorders}, year = {2006}, doi = {10.1097/01.wad.0000213870.40300.21}, pmid = {17135805}, url = {https://doi.org/10.1097/01.wad.0000213870.40300.21} } @article{cummings2020-32695874, author = {Cummings, J. and Lee, G. and Ritter, A. and Sabbagh, M. and Zhong, K.}, title = {{Alzheimer's disease drug development pipeline: 2020}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2020}, doi = {10.1002/trc2.12050}, pmid = {32695874}, url = {https://doi.org/10.1002/trc2.12050} } @article{frisoni2022-34815562, author = {Frisoni, G. B. and Altomare, D. and Thal, D. R. and Ribaldi, F. and van der Kant, R. and Ossenkoppele, R. and Blennow, K. and Cummings, J. and others}, title = {{The probabilistic model of Alzheimer disease: the amyloid hypothesis revised}}, journal = {Nature reviews. Neuroscience}, year = {2022}, doi = {10.1038/s41583-021-00533-w}, pmid = {34815562}, url = {https://doi.org/10.1038/s41583-021-00533-w} } @article{liss2021-33458891, author = {Liss, J. L. and Seleri Assunção, S. and Cummings, J. and Atri, A. and Geldmacher, D. S. and Candela, S. F. and Devanand, D. P. and Fillit, H. M. and others}, title = {{Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis}}, journal = {Journal of internal medicine}, year = {2021}, doi = {10.1111/joim.13244}, pmid = {33458891}, url = {https://doi.org/10.1111/joim.13244} } @article{cummings2022-35516416, author = {Cummings, J. and Lee, G. and Nahed, P. and Kambar, M. E. Z. N. and Zhong, K. and Fonseca, J. and Taghva, K.}, title = {{Alzheimer's disease drug development pipeline: 2022}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2022}, doi = {10.1002/trc2.12295}, pmid = {35516416}, url = {https://doi.org/10.1002/trc2.12295} } @article{cummings2024-38659717, author = {Cummings, J. and Zhou, Y. and Lee, G. and Zhong, K. and Fonseca, J. and Cheng, F.}, title = {{Alzheimer's disease drug development pipeline: 2024}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2024}, doi = {10.1002/trc2.12465}, pmid = {38659717}, url = {https://doi.org/10.1002/trc2.12465} } @article{cummings2018-29955663, author = {Cummings, J. and Lee, G. and Ritter, A. and Zhong, K.}, title = {{Alzheimer's disease drug development pipeline: 2018}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2018}, doi = {10.1016/j.trci.2018.03.009}, pmid = {29955663}, url = {https://doi.org/10.1016/j.trci.2018.03.009} } @article{bloniecki2017-28269767, author = {Bloniecki, V. and Aarsland, D. and Blennow, K. and Cummings, J. and Falahati, F. and Winblad, B. and Freund-Levi, Y.}, title = {{Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2017}, doi = {10.3233/jad-160758}, pmid = {28269767}, url = {https://doi.org/10.3233/jad-160758} } @article{cummings2023-37251912, author = {Cummings, J. and Zhou, Y. and Lee, G. and Zhong, K. and Fonseca, J. and Cheng, F.}, title = {{Alzheimer's disease drug development pipeline: 2023}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2023}, doi = {10.1002/trc2.12385}, pmid = {37251912}, url = {https://doi.org/10.1002/trc2.12385} } @article{cummings2017-29067343, author = {Cummings, J. and Lee, G. and Mortsdorf, T. and Ritter, A. and Zhong, K.}, title = {{Alzheimer's disease drug development pipeline: 2017}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2017}, doi = {10.1016/j.trci.2017.05.002}, pmid = {29067343}, url = {https://doi.org/10.1016/j.trci.2017.05.002} } @article{cummings2021-34095440, author = {Cummings, J. and Lee, G. and Zhong, K. and Fonseca, J. and Taghva, K.}, title = {{Alzheimer's disease drug development pipeline: 2021}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2021}, doi = {10.1002/trc2.12179}, pmid = {34095440}, url = {https://doi.org/10.1002/trc2.12179} } @article{ballard2020-32939050, author = {Ballard, C. and Aarsland, D. and Cummings, J. and O'Brien, J. and Mills, R. and Molinuevo, J. L. and Fladby, T. and Williams, G. and others}, title = {{Drug repositioning and repurposing for Alzheimer disease}}, journal = {Nature reviews. Neurology}, year = {2020}, doi = {10.1038/s41582-020-0397-4}, pmid = {32939050}, url = {https://doi.org/10.1038/s41582-020-0397-4} } @article{cummings2019-31421681, author = {Cummings, J. and Passmore, P. and McGuinness, B. and Mok, V. and Chen, C. and Engelborghs, S. and Woodward, M. and Manzano, S. and others}, title = {{Souvenaid in the management of mild cognitive impairment: an expert consensus opinion}}, journal = {Alzheimer's research \& therapy}, year = {2019}, doi = {10.1186/s13195-019-0528-6}, pmid = {31421681}, url = {https://doi.org/10.1186/s13195-019-0528-6} } @article{salzman2008-18494535, author = {Salzman, C. and Jeste, D. V. and Meyer, R. E. and Cohen-Mansfield, J. and Cummings, J. and Grossberg, G. T. and Jarvik, L. and Kraemer, H. C. and others}, title = {{Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy}}, journal = {The Journal of clinical psychiatry}, year = {2008}, doi = {10.4088/jcp.v69n0602}, pmid = {18494535}, url = {https://doi.org/10.4088/jcp.v69n0602} } @article{angioni2024-39350367, author = {Angioni, D. and Cummings, J. and Lansdall C, J. and Middleton, L. and Sampaio, C. and Gauthier, S. and Cohen, S. and Petersen R, C. and others}, title = {{Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2024}, doi = {10.14283/jpad.2024.112}, pmid = {39350367}, url = {https://doi.org/10.14283/jpad.2024.112} } @article{cummings2019-31334330, author = {Cummings, J. and Lee, G. and Ritter, A. and Sabbagh, M. and Zhong, K.}, title = {{Alzheimer's disease drug development pipeline: 2019}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2019}, doi = {10.1016/j.trci.2019.05.008}, pmid = {31334330}, url = {https://doi.org/10.1016/j.trci.2019.05.008} } @article{cummings2024-37955845, author = {Cummings, J. and Osse, A. M. L. and Cammann, D. and Powell, J. and Chen, J.}, title = {{Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease}}, journal = {BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy}, year = {2024}, doi = {10.1007/s40259-023-00633-2}, pmid = {37955845}, url = {https://doi.org/10.1007/s40259-023-00633-2} } @article{cummings2021-34585212, author = {Cummings, J. and Aisen, P. and Apostolova, L. G. and Atri, A. and Salloway, S. and Weiner, M.}, title = {{Aducanumab: Appropriate Use Recommendations}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2021}, doi = {10.14283/jpad.2021.41}, pmid = {34585212}, url = {https://doi.org/10.14283/jpad.2021.41} } @article{cummings2023-37060386, author = {Cummings, J.}, title = {{Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics}}, journal = {Drugs}, year = {2023}, doi = {10.1007/s40265-023-01858-9}, pmid = {37060386}, url = {https://doi.org/10.1007/s40265-023-01858-9} } @article{cummings2022-35542993, author = {Cummings, J. and Rabinovici, G. D. and Atri, A. and Aisen, P. and Apostolova, L. G. and Hendrix, S. and Sabbagh, M. and Selkoe, D. and others}, title = {{Aducanumab: Appropriate Use Recommendations Update}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2022}, doi = {10.14283/jpad.2022.34}, pmid = {35542993}, url = {https://doi.org/10.14283/jpad.2022.34} } @article{hampel2021-34239130, author = {Hampel, H. and Cummings, J. and Blennow, K. and Gao, P. and Jack, C. R. and Vergallo, A.}, title = {{Developing the ATX(N) classification for use across the Alzheimer disease continuum}}, journal = {Nature reviews. Neurology}, year = {2021}, doi = {10.1038/s41582-021-00520-w}, pmid = {34239130}, url = {https://doi.org/10.1038/s41582-021-00520-w} } @article{raskin2015-26412218, author = {Raskin, J. and Cummings, J. and Hardy, J. and Schuh, K. and Dean, R. A.}, title = {{Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions}}, journal = {Current Alzheimer research}, year = {2015}, doi = {10.2174/1567205012666150701103107}, pmid = {26412218}, url = {https://doi.org/10.2174/1567205012666150701103107} } @article{aisen2020-32463066, author = {Aisen, P. S. and Cummings, J. and Doody, R. and Kramer, L. and Salloway, S. and Selkoe, D. J. and Sims, J. and Sperling, R. A. and others}, title = {{The Future of Anti-Amyloid Trials}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2020}, doi = {10.14283/jpad.2020.24}, pmid = {32463066}, url = {https://doi.org/10.14283/jpad.2020.24} } @article{ismail2017-28059789, author = {Ismail, Z. and Agüera-Ortiz, L. and Brodaty, H. and Cieslak, A. and Cummings, J. and Fischer, C. E. and Gauthier, S. and Geda, Y. E. and others}, title = {{The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2017}, doi = {10.3233/jad-160979}, pmid = {28059789}, url = {https://doi.org/10.3233/jad-160979} } @article{gauthier2010-20096151, author = {Gauthier, S. and Cummings, J. and Ballard, C. and Brodaty, H. and Grossberg, G. and Robert, P. and Lyketsos, C.}, title = {{Management of behavioral problems in Alzheimer's disease}}, journal = {International psychogeriatrics}, year = {2010}, doi = {10.1017/s1041610209991505}, pmid = {20096151}, url = {https://doi.org/10.1017/s1041610209991505} }